Bullish Moving Averages
15
Bearish Moving Averages
1
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
2030.00Today’s High
2109.2052W low
1296.0052W High
2109.20Open Price
2100.00Prev. Close
2028.5500Volume
342755.00Value
698500414.50Fundamentals
Market Cap
10439.90
Price to Earnings
81.70
Price to Book Value
9.50
Dividend Yield
0.20
PE to Growth
-7.70
Op Revenue TTM
1207.71
Net Profit TTM
127.82
Cash From Operating Activity
264.07
Return on Equity %
11.66
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
42
Week
38.5
Month
39.4
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
2059.03
PIVOT
First Resistance
2088.07
Second Resistance
2138.23
Third Resistance
2167.27
First Support
2008.87
Second Support
1979.83
Third Support
1929.67
Relative Strength Index
59.17
Money Flow Index
61.6
MACD
33.44
MACD Signal
26.95
Average True Range
61.06
Average Directional Index
16.41
Rate of Change (21)
2.66
Rate of Change (125)
19.31
Commodity Channel Index
128.2
Williams %R
-36.1
BETA
1 Month
1.02
3 Month
0.53
1 Year
0.61
3 Year
0.38
PRICE CHANGE ANALYSIS
↑ 3.03%
1 Week
Low
High
1979.25
2109.2
↑ 2.66%
1 Month
Low
High
1911.55
2109.2
↑ 18.85%
3 Months
Low
High
1671.6
2109.2
↑ 21.71%
6 Months
Low
High
1450
2109.2
↑ 39.49%
1 Year
Low
High
1296
2109.2
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 294.29 | 274.60 | 287.46 | 259.07 | 273.54 | 271.35 | 282.99 | 259.44 | 262.48 | 213.68 | 245.26 | |
| Operating Expenses Qtr | 218.35 | 210.58 | 217.98 | 198.03 | 196.69 | 199.05 | 205.00 | 195.99 | 172.28 | 164.46 | 171.78 | |
| Operating Profit Qtr | 73.92 | 58.83 | 67.47 | 58.26 | 67.72 | 65.50 | 75.06 | 61.03 | 45.72 | 47.78 | 70.17 | |
| EBIDT Qtr Cr | 75.94 | 64.01 | 69.48 | 61.04 | 76.86 | 72.29 | 77.99 | 63.45 | 90.20 | 49.22 | 73.47 | |
| Depreciation Qtr | 25.24 | 24.14 | 21.37 | 19.99 | 22.23 | 21.95 | 20.40 | 20.37 | 11.95 | 11.54 | 11.74 | |
| Net Profit Qtr | 31.78 | 26.70 | 31.28 | 26.13 | 39.93 | 32.83 | 37.82 | 28.38 | 63.11 | 24.86 | 44.47 | |
| Basic EPS Qtr | 6.20 | 5.21 | 6.11 | 5.10 | 7.80 | 6.41 | 7.39 | 5.54 | 12.33 | 4.86 | 8.70 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1115.42 | 1087.32 | 1133.13 | 864.76 | 694.62 | |
| Operating Expenses Annual Cr | 844.94 | 796.73 | 812.05 | 576.74 | 492.70 | |
| Operating Profit Annual | 258.48 | 269.31 | 305.08 | 239.37 | 172.60 | |
| Operating Profit Margin Annual % | 23.17 | 24.77 | 26.92 | 27.68 | 24.85 | |
| Total Expenses Annual Cr | 958.01 | 908.38 | 887.25 | 618.71 | 530.11 | |
| EBIDT Annual Cr | 270.48 | 290.59 | 321.09 | 288.02 | 201.92 | |
| EBIDT Annual margin % | 24.25 | 26.73 | 28.34 | 33.31 | 29.07 | |
| Depreciation | 90.73 | 84.96 | 55.88 | 36.20 | 30.85 | |
| PAT Before ExtraOrdinary Items Annual Cr | 115.89 | 138.95 | 192.24 | 197.56 | 112.05 | |
| Net Profit Annual | 115.89 | 138.95 | 192.24 | 197.56 | 112.05 | |
| Basic EPS Annual | 22.63 | 27.14 | 37.58 | 38.81 | 22.32 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 1031.19 | 936.02 | 824.13 | 708.93 | 512.38 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 207.14 | 245.01 | 247.58 | 66.52 | 42.25 | |
| Total Current Liabilities Annual Cr | 234.37 | 253.27 | 272.83 | 158.00 | 133.66 | |
| Total Capital Plus Liabilities Annual Cr | 1472.70 | 1434.29 | 1344.54 | 933.44 | 688.30 | |
| Fixed Assets Annual | 941.96 | 1085.28 | 319.84 | 251.29 | 218.77 | |
| Total Non Current Assets Annual | 1200.26 | 1168.86 | 1005.01 | 417.07 | 386.23 | |
| Total Current Assets Annual | 272.44 | 265.44 | 339.53 | 516.37 | 302.07 | |
| Total Assets Annual | 1472.70 | 1434.29 | 1344.54 | 933.44 | 688.30 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 4.20 | 12.11 | 21.70 | 27.11 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 269.01 | 237.74 | 237.15 | 202.50 | 156.13 | |
| Cash from Investing Activity Annual | -81.00 | 46.72 | -733.79 | 73.53 | -51.13 | |
| Cash from Financing Annual Activity | -183.00 | -287.87 | 173.14 | -26.33 | -46.37 | |
| Net Cash Flow Annual | - | -3.40 | -323.50 | 249.70 | 58.63 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 201.30 | 182.78 | 161.05 | 138.69 | 101.20 | |
| ROE Annual % | 11.23 | 14.84 | 23.32 | 27.86 | 21.86 | |
| ROCE Annual % | 14.51 | 17.41 | 24.74 | 32.47 | 30.84 | |
| Total Debt to Total Equity Annual | 0.00 | 0.09 | 0.31 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 24.51 | 27.25 | 28.74 | 35.29 | 30.35 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 333.54 | 293.42 | 309.72 | 280.14 | 283.77 | 292.08 | 304.68 | 282.90 | 311.58 | 295.66 | 308.19 | |
| Operating Expenses Qtr | 251.02 | 226.27 | 233.69 | 214.15 | 212.26 | 214.97 | 221.32 | 211.37 | 231.05 | 217.72 | 212.38 | |
| Operating Profit Qtr | 79.98 | 64.85 | 74.81 | 62.94 | 70.29 | 70.49 | 79.03 | 68.49 | 74.85 | 75.33 | 90.24 | |
| EBIDT Qtr Cr | 82.52 | 67.15 | 76.03 | 65.99 | 71.51 | 77.11 | 83.37 | 71.53 | 80.52 | 77.94 | 95.82 | |
| Depreciation Qtr | 26.42 | 24.99 | 22.24 | 20.82 | 23.43 | 23.03 | 21.58 | 21.17 | 17.99 | 16.88 | 15.04 | |
| Net Profit Qtr | 36.41 | 27.16 | 35.45 | 28.80 | 33.36 | 35.80 | 40.33 | 33.40 | 39.99 | 41.04 | 58.27 | |
| Basic EPS Qtr | 7.11 | 5.30 | 6.92 | 5.62 | 6.51 | 6.99 | 7.88 | 6.53 | 7.81 | 8.02 | 11.39 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1216.83 | 1163.43 | 1245.96 | 1010.03 | 864.97 | |
| Operating Expenses Annual Cr | 925.13 | 859.91 | 885.54 | 711.98 | 623.58 | |
| Operating Profit Annual | 282.58 | 288.30 | 342.79 | 286.00 | 232.82 | |
| Operating Profit Margin Annual % | 23.22 | 24.78 | 27.51 | 28.32 | 26.92 | |
| Total Expenses Annual Cr | 1042.14 | 975.93 | 968.51 | 765.71 | 671.19 | |
| EBIDT Annual Cr | 291.69 | 303.52 | 360.41 | 298.05 | 241.39 | |
| EBIDT Annual margin % | 23.97 | 26.09 | 28.93 | 29.51 | 27.91 | |
| Depreciation | 94.47 | 89.22 | 63.22 | 45.94 | 39.27 | |
| PAT Before ExtraOrdinary Items Annual Cr | 128.46 | 143.39 | 214.69 | 183.35 | 128.07 | |
| Net Profit Annual | 127.82 | 142.88 | 214.18 | 183.10 | 127.33 | |
| Basic EPS Annual | 24.87 | 27.91 | 41.66 | 35.79 | 25.25 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 1096.16 | 988.23 | 888.17 | 706.60 | 523.50 | |
| Minority Interest Liability Annual Cr | 3.12 | 2.48 | 0.00 | 1.46 | 1.66 | |
| Total Non Current Liabilities Annual Cr | 209.91 | 245.93 | 340.58 | 92.39 | 57.60 | |
| Total Current Liabilities Annual Cr | 245.87 | 264.97 | 301.55 | 203.96 | 169.48 | |
| Total Capital Plus Liabilities Annual Cr | 1555.06 | 1501.61 | 1530.29 | 1004.41 | 752.23 | |
| Fixed Assets Annual | 542.24 | 685.50 | 610.02 | 252.86 | 209.01 | |
| Total Non Current Assets Annual | 1239.23 | 1198.87 | 1137.17 | 395.96 | 355.17 | |
| Total Current Assets Annual | 315.83 | 302.73 | 393.12 | 608.46 | 397.06 | |
| Total Assets Annual | 1555.06 | 1501.61 | 1530.29 | 1004.41 | 752.23 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 4.99 | 12.52 | 26.79 | 30.94 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 264.07 | 247.09 | 253.27 | 249.03 | 215.00 | |
| Cash from Investing Activity Annual | -89.41 | 46.79 | -737.57 | 61.70 | -104.83 | |
| Cash from Financing Annual Activity | -181.20 | -292.33 | 162.52 | -32.69 | -55.32 | |
| Net Cash Flow Annual | - | 1.56 | -321.78 | 278.04 | 54.85 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 214.59 | 193.46 | 173.56 | 138.52 | 103.72 | |
| ROE Annual % | 11.66 | 14.45 | 24.11 | 25.91 | 24.32 | |
| ROCE Annual % | 15.06 | 17.32 | 24.18 | 31.49 | 34.68 | |
| Total Debt to Total Equity Annual | 0.00 | 0.08 | 0.29 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 24.15 | 26.43 | 29.34 | 29.86 | 28.18 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Hdfc Mutual Fund - Hdfc Focused 30 Fund | 6.65 | 75287211 | - | - |
| Franklin India Smaller Companies Fund | 2.99 | 75287213 | - | - |
| Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Flexi Cap Fund | 1.18 | 75287216 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Sushil Kanubhai Shah | 2.5 | 75287202 | 0 | 0 |
| Metz Advisory Llp | 30.63 | 75287205 | 1.91 | 0 |
| Duru Shah Family Trust | 9.69 | 75287206 | 0 | 0 |
| Sushil Shah Family Trust | 4.99 | 75287207 | 0 | 0 |
| Duru Sushil Shah | 1.49 | 75287208 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Hdfc Mutual Fund - Hdfc Focused 30 Fund | 6.65 | 75287211 |
| Uti Large Cap Fund | 5.45 | 75287212 |
| Franklin India Smaller Companies Fund | 2.99 | 75287213 |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | 2.56 | 75287214 |
| Quant Mutual Fund - Quant Small Cap Fund | 1.86 | 75287215 |
| Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Flexi Cap Fund | 1.18 | 75287216 |
| J P Morgan Funds | 2.22 | 75287222 |
| Caisse De Depot Et Placement Du Quebec - First Sentier Investors International Im Limited | 1.44 | 75287223 |
| Jpmorgan Indian Investment Trust Plc | 1.39 | 75287224 |
| The Scottish Oriental Smaller Companies Trustplc | 1.19 | 75287227 |
| Fssa Indian Subcontinent Fund As Sub Fund Of First Sentier Investors Global Umbrella Fund Plc | 1.14 | 75287225 |
| Sbi Life Insurance Co. Ltd | 2.14 | 75287218 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Nov 17, 2023 | 4 | INTERIM | Nov 17, 2023 | Equity Share |
| Feb 23, 2023 | 8 | INTERIM | Feb 23, 2023 | Equity Share |
| Feb 21, 2022 | 8 | INTERIM | Feb 22, 2022 | Equity Share |
| Feb 17, 2021 | 8 | INTERIM | Feb 19, 2021 | Equity Share |
| Feb 13, 2020 | 8 | INTERIM | Feb 15, 2020 | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 21, 2024 | Audited Results | - |
| Feb 02, 2024 | Quarterly Results | - |
| Nov 04, 2023 | Quarterly Results & Interim Dividend | - |
| Aug 02, 2023 | Quarterly Results | - |
| May 16, 2023 | Audited Results | - |
| Feb 10, 2023 | Quarterly Results & Interim Dividend | - |
| Nov 08, 2022 | Quarterly Results | - |
| Aug 10, 2022 | Quarterly Results | - |
| Jul 18, 2022 | Others | Inter alia, to consider and approve the revised Audited Standalone Financial results of the Company for the Quarter and Year ended March 31, 2022. |
| May 24, 2022 | Audited Results | - |
| Feb 11, 2022 | Quarterly Results & Interim Dividend | - |
| Nov 10, 2021 | Quarterly Results | - |
| Aug 06, 2021 | Quarterly Results & Others | - |
| May 27, 2021 | Audited Results | - |
| Feb 10, 2021 | Quarterly Results & Interim Dividend | - |
| Jan 17, 2021 | Others | General Purpose |
| Nov 11, 2020 | Quarterly Results | - |
| Aug 11, 2020 | Quarterly Results | - |
| May 29, 2020 | Audited Results | - |
| Feb 06, 2020 | Quarterly Results & Interim Dividend | - |
| Nov 11, 2019 | Quarterly Results | - |
| May 13, 2019 | Audited Results & Final Dividend | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
05 Jul 2024
Metropolis Healthcare Ltd - 542650 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2024
28 Jun 2024
Metropolis Healthcare Ltd - 542650 - Closure of Trading Window
The trading window will be closed with effect from July 01, 2024 and shall remain closed up to 48 hours after the declaration of the Financial Results for the quarter ending June 30, 2024.
15 Jun 2024
Metropolis Healthcare Ltd - 542650 - Grant Of Restrictive Stock Units (Rsus) Under The Metropolis Healthcare Limited - Restrictive Stock Unit Plan, 2020 (MHL-RSU Plan, 2020)
The Nomination and Remuneration Committee of the Board of Directors of the Company vide circular resolution dated June 15, 2024, has approved grant of 58,000 RSUs under MHL-RSU Plan, 2020 to the eligible employee(s) of the Company.
11 Jun 2024
Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Sushil Kanubhai Shah & PACs
10 Jun 2024
Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the officials of the Company will be meeting Investors on June 13, 2024.
30 May 2024
Metropolis Healthcare Ltd - 542650 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended March 31, 2024.
30 May 2024
Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the officials of the Company will be meeting Investors on June 05, 2024.
28 May 2024
Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Q4 FY24 earnings conference call held on May 22, 2024.
23 May 2024
Metropolis Healthcare to invest in new segments, plans expansion into underserved areas
Aligned with its expansion plans, Metropolis aims to boost its collection centre networks and enhance service standards, particularly in Tier II and III markets.
22 May 2024
Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) of SEBI (LODR) Regulations, 2015, the Company will be meeting with investors as per the details attached herewith this letter.
